We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




New X-Ray Technique Targets Tumors and Terror

By Biotechdaily staff writers
Posted on 24 Dec 2007
Scientists have developed a new X-ray technique that could be used to more effectively detect human cancers in addition to hidden explosives and drugs.

Prof. More...
Robert Cernik and colleagues from the School of Materials at the University of Manchester (UK) have constructed a prototype color three-dimensional (3D) X-ray system that allows substances at each point of an image to be clearly identified. The technique developed by the scientists is known as tomographic energy dispersive diffraction imaging (TEDDI).

The new technique harnesses all the wavelengths present in an X-ray beam to create probing 3D images. The technique improves on existing methods by allowing detailed images to be created with one very simple scanning motion and makes use of a sophisticated detector and collimator engineering developed at Daresbury Laboratory (Cheshire, UK), Rutherford Appleton Laboratory (Swindon, UK), and the University of Cambridge (UK).

Scientists believe this sophisticated engineering will reduce the time taken to create a sample scan from hours to just a few minutes. This shorter period would eliminate the problem of radiation damage, allowing biopsy samples to be evaluated and normal tissue types to be distinguished from abnormal.

Prof. Cernik noted, "We have demonstrated a new prototype X-ray imaging system that has exciting possibilities across a wide range of disciplines including medicine, security scanning, and aerospace engineering. Current imaging systems such as spiral CAT [computed axial tomography] scanners do not use all the information contained in the X-ray beam. We use all the wavelengths present to give a color X-ray image. This extra information can be used to fingerprint the material present at each point in a 3D image. The TEDDI method is highly applicable to biomaterials, with the possibility of specific tissue identification in humans or identifying explosives, cocaine, or heroin in freight. It could also be used in aerospace engineering, to establish whether the alloys in a weld have too much strain.”

To develop the technology, Prof. Cernik and his team have had to overcome two major technologic challenges. The first was to produce pixellated spectroscopy-grade energy sensitive detectors. The second challenge was to build a device known as a 2D collimator, which filters and directs streams of scattered X-rays. The collimator device needed to have a high aspect ratio of 6000:1, meaning that the ratio of its width to its length is more than that of the channel tunnel (Chunnel or Eurotunnel). This device was built using a laser drilling method in collaboration with the University of Cambridge.

Using detectors made from silicon, the Manchester team has been restricted to looking at thin samples or light atom structures. But they are developing new, high purity, high atomic weight, semiconductor detector materials that will remove this difficulty and drastically speed up scanning times. This study was reported in the Journal of the Royal Society Interface, published online November 28, 2007.

A University of Manchester-led project, called HEXITEC, has just started to make new material.


Related Links:
University of Manchester

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Real-Time PCR System
Gentier 96T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.